AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat

[ad_1] Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase in revenues. The numbers exceeded estimates. The company reported worldwide net revenues of $14.46 billion for the…







